IDapagliflozin Tetraacetate, iDapagliflozin ephakathi
| Igama leMchiza | I-Dapagliflozin Tetraacetate;I-Dapagliflozin ephakathi |
| Izithethantonye | (2R, 3R, 5R, 6R) -6- (Acetoxymethyl) -2- (4-chloro-3- (4-ethoxybenzyl) phenyl) tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate; [(2R,3R,4R,5S,6S)-3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate |
| Inombolo yeCAS | 461432-25-7 |
| Ifomula yeemolekyuli | C₂₉H₃₃ClO₁₀ |
| Imbonakalo | Mhlophe ukuya kuMhlophe Okuqinileyo |
| Indawo yokunyibilika | 180.7±30.5 °C |
| Ubunzima beMolekyuli | 577.019 |
| Ugcino | Umoya ongasebenziyo |
| Udidi | Imigangatho;Pharmaceutical/API Drug Ukungcola/Metabolites; |
| Usetyenziso | I-Dapagliflozin Tetraacetate iphuma kwi-Dapagliflozin [D226255], i-sodium-glucose transporter 2 inhibitor. |
| Iimbekiselo | Kasichayanula, S. et al.: Isifo seswekile, ukutyeba kakhulu kunye ne-Metabolism 13, 47 (2011);Bernhardson, D. et al.: Org.Iproc.Res.Dev., 18, 57 (2014); |
Igama lemveliso:I-Dapagliflozin Tetraacetate, i-Dapagliflozin ephakathi, iNombolo ye-CAS: 461432-25-7
Izithethantonye:
I-Dapagliflozin Tetraacetate, i-Dapagliflozin ephakathi;
(2R, 3R, 5R, 6R) -6- (Acetoxymethyl) -2- (4-chloro-3- (4-ethoxybenzyl) phenyl) tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate;
[(2R,3R,4R,5S,6S) -3,4,5-triacetyloxy-6-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]oxan-2-yl]methyl acetate;
(1s) -1,5-anhydro-1-c-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-d-glucitoltetraacetate;
I-Acetic acid (2R, 3R, 4R, 5S, 6S) -3,4,5 - triacetoxy-6-[4-chloro -3- (4-ethoxy-benzyl) -phenyl] - tetrahydro-pyran-2-ylmethyl ester
(1S) -2,3,4,6-Tetra-O-acetyl-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol
I-Dapagliflozin-A3
(1S) -1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol tetraacetate
I-Anhui Cheer-yethu iTekhnoloji yezoNyango Co., Ltd yasekwa ngo-2015. Emva kokuqhubela phambili ngokuqhubekayo, inkampani iye yaphuhliswa yaba lishishini loxubo lobuchwephesha oludibanisa uphando lwemichiza kunye neyeza lebhayoloji, i-pharmaceutical intermediates, i-APIs, amalungiselelo kunye nokuthengiswa kwemveliso.Ngophando kunye nophuhliso kunye nolutsha kwinkalo yeyeza kunye nempilo efana neziyobisi ezigqityiweyo, ii-APIs kunye nabaphakathi, inkampani ibambelela kumgaqo womthengi kuqala, inkonzo ethembekileyo, umgangatho wokuqala, inzuzo efanayo ", ngovavanyo olugqibeleleyo, umgangatho ophezulu. inkonzo, ibonelela ngolungelelwaniso lwesiko, ukwenziwa kwekhontrakthi kunye neenkonzo zokusetyenzwa.
1. Nawuphi na umbuzo okanye umyalezo uya kuphendulwa kwiiyure ezili-12.
2. Umvelisi oqeqeshiweyo.Wamkelekile ukutyelela iwebhusayithi yethu.
3. I-API, i-Intermediate iyafumaneka, sinokunikela nge-Custom Synthesis, kunye nokubhaliswa kwakhona.
4. Ukuhanjiswa ngokukhawuleza.
5. Iinkonzo emva kokuthengisa
